ClinicalTrials.gg
RecruitingNCT07180537Updated Aug 10, 2026

Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders

An interventional study of Creating Health Online Course and Delayed access to Creating Health Online Course in Rheumatoid Arthritis, Sjogren's Syndrome and Systemic Lupus Erythematosus, sponsored by Terry L. Wahls. Recruiting at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-08-10.

Primary conditionSjogren's SyndromeRegistry: Arthritis, RheumatoidReclassifiedWhy we changed it
Registry
Arthritis, Rheumatoid — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sjogren's Syndrome
Why
  1. The study's listed conditions name Sjogren's Syndrome, a narrower term within Arthritis, Rheumatoid.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Terry L. Wahls · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), psoriatic arthritis (PsA), anxiety disorders, depressive disorders and moderate depression.

Additionally, investigators will assess the program's effectiveness, as well as the challenges and facilitators involved in using an online wellness program to reduce fatigue and enhance the quality of life in patients suffering from these conditions.

Read the detailed description

The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), psoriatic arthritis (PsA), anxiety disorders, depressive disorders, and moderate depression. . Additionally, we will assess the program's effectiveness, as well as the challenges and facilitators involved in using an online wellness program to reduce fatigue and enhance the quality of life in patients suffering from these conditions.

Once the eligibility criteria are established and consent is obtained, investigators will invite study participants randomized to the intervention arm to the online course via email. Participants will be required to create a password to access the course. The online course and supplementary resources will be hosted on a secure website through the UIowa Canvas Classroom platform. Participants will progress through the online health course modules similarly to a non-graded online course. Within the course, there are exercises and personal assessments designed to enhance the participants' experience and success.

The course will cover various topics, including modules on developing an inner game plan, a food intervention plan, a physical intervention plan, and an increased resilience plan. The fourth module will propose various strategies to improve health beyond diet and exercise, such as the use of supplements, light therapy, detoxification, improved sleep, stress reduction, and other strategies to enhance bodily resilience.

Participants are encouraged to communicate and collaborate with their healthcare teams to personalize their treatment and determine whether the strategies suggested in the course are appropriate for their individual healthcare needs. This study aims to provide dietary education to a broader sample size than previously studied, including patients with limited resources such as financial constraints and geographic barriers that restrict access to registered dietitians experienced in dietary instruction for various rheumatological conditions. There is a growing interest in delivering education and support through an online platform to improve diet quality and self-care practices for autoimmune patients.

This study will utilize a randomized single-blind waitlist control design to evaluate the impact of the online course, which includes materials covering a modified Paleolithic elimination (MPE) diet, nutrient-dense vegetarian diets, Mediterranean diets, stress reduction techniques, and exercise strategies designed for autoimmune patients. Data will be collected in the short term (after 3 months) and long term (at the end of 6 months) to analyze the effects of the online wellness program on quality of life (QoL) and related outcomes among individuals with RA, SS, SLE, MCTD, PsA, anxiety disorders, depressive disorders, and moderate depression. .

Investigators will request that study participants complete their baseline assessments within approximately 7 to 14 days following consent. Participants will receive an individual link to their baseline assessments via REDCap. Patients will be randomized into different study arms based on their baseline fatigue severity scores.

The proposed study will be conducted entirely online. The schedule will include three virtual visits at three-month intervals (months 0, 3, and 6). Online questionnaires will be distributed via REDCap to assess fatigue, quality of life, and dietary information according to the study schedule (months 0, 3, and 6).

02

Conditions studied

  • Rheumatoid Arthritis
  • Sjogren's Syndrome
  • Systemic Lupus Erythematosus
  • Mixed Connective Tissue Disease
  • Psoriatic Arthritis
  • Anxiety Disorders
  • Depressive Disorders
  • Moderate Depression
  • Moderate Anxiety

Keywords

  • diet
  • self-care
  • internet course
  • anxiety
  • depression
  • Sjogren's
  • rheumatoid arthritis
  • lupus
  • fatigue
  • arthritis
03

In context

Sjogren's Syndrome Reclassified

330 studies on the registry are indexed under Sjogren's Syndrome; 99 are open to participants now.

This study's planned enrollment of 400 is above the median of 50 across 218 interventional studies indexed under Sjogren's Syndrome.

Browse Sjogren's Syndrome studies →

Lead sponsor

Terry L. Wahls is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Compared within Sjogren's Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Arthritis, Rheumatoid. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. A diagnosis of one of the following: Rheumatoid Arthritis (RA), Sjogren's Syndrome, Systemic lupus erythematosus (SLE), Mixed connective tissue disease (MCTD), or Psoriatic Arthritis (PsA), as documented by their treating specialist or primary care provider, as reported by the participant.
  2. Must be age 18 and older, at time of consent.
  3. Must be fluent in both speaking and reading English.

    *Study participant must be able to read and comprehend document and speak with study staff about study document content. Study staff will use discretion in determining whether the study participant can clearly communicate with staff and comprehend the study material during the consent call or prior to the call.

  4. Must have access to high-speed internet with devices capable of audio/video streaming.
  5. Must be willing to participate in an online health course designed to improve dietary intake and self-care routines to help improve cellular function and health, and complete online surveys over the course of a 6-month period.
  6. Individuals must pass the Short Portable Mental Status Questionnaire with scores for normal mental functioning (up to 2 errors). Cognitive impairment as measured by the SPMS Questionnaire could interfere with the completion of the online course.

SCORING* 0-2 errors: normal mental functioning 3-4 errors: mild cognitive impairment 5-7 errors: moderate cognitive impairment 8-10 errors: severe cognitive impairment

*Allow one more error for a subject with only a grade school education. Allow one less error for a subject with education beyond high school.

Source: Pfeiffer, E. (1975). A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of American Geriatrics Society. 23, 433-41.

Exclusion criteria

Exclusion criteria:

  1. Inability to provide , including participation in a consent call conducted via Zoom with the study team during business hours (8:00 a.m. to 5:00 p.m. Central Time (Chicago)).
  2. Participation in another research study investigating an intervention (treatments, medications, diet, or exercise). Participation in observation-only studies are not excluded.
  3. Currently following a modified Paleolithic, low-fat nutrient-dense vegetarian, or Mediterranean diet with 75% OR greater reported compliance.
  4. Any diagnosis or condition that is from starting a gentle exercise program (ex. poorly controlled diseases of the heart, kidney, or liver in the prior 12 months, or severe psychiatric disease, e.g., schizophrenia, making adherence to study procedures difficult.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Immediate Intervention: Creating Health Online course

    This arm will begin the intervention immediately after randomization

    Behavioral: Creating Health Online Course

  • Other
    Delayed Intervention: Creating Health Online course

    This is the control arm.

    Behavioral: Delayed access to Creating Health Online Course

Interventions

  • BehavioralCreating Health Online Course

    Immediate access to an online audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

    Also known as: Online wellness course

  • BehavioralDelayed access to Creating Health Online Course

    Delayed access (12-week delay) to an online audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

    Also known as: Online wellness course

06

What researchers measure

Primary outcomes

  1. Modified Fatigue Impact Scale (MFIS)

    Change in MFIS survey questions, scores range from 0-84, lower score is better.

    Time frame: Day 0 to Month 3

  2. Modified Fatigue Impact Scale (MFIS)

    Change in MFIS survey questions, scores range from 0-84, lower score is better.

    Time frame: Day 0 to Month 6

  3. Fatigue Severity Scale (FFS)

    Change in FSS survey questions, scores range from 1-63, lower score is better.

    Time frame: Day 0 to Month 3

  4. Fatigue Severity Scale (FFS)

    Change in FSS survey questions, scores range from 1-63, lower score is better.

    Time frame: Day 0 to Month 6

  5. Short form 36 (SF 36)

    Change in (SF 36) survey questions mean scores, range 0-100, higher number is better

    Time frame: Day 0 to Month 3

  6. Short form 36 (SF 36)

    Change in (SF 36) survey questions mean scores, range 0-100, higher number is better

    Time frame: Day 0 to Month 6

  7. Rapid 3

    Change in Rapid 3 survey questions mean scores, range 0-30, lower number is better

    Time frame: Day 0 to Month 3

  8. Rapid 3

    Change in Rapid 3 survey questions mean scores, range 0-30, lower number is better

    Time frame: Day 0 to Month 6

Secondary outcomes

  1. Mediterranean and Paleo Diet Screener

    Mediterranean and Paleo Diet Screener questions, scores range 0-14, higher is better

    Time frame: Baseline

  2. Mediterranean and Paleo Diet Screener

    Mediterranean and Paleo Diet Screener questions, scores range 0-14, higher is better

    Time frame: Month 3

  3. Mediterranean and Paleo Diet Screener

    Mediterranean and Paleo Diet Screener questions, scores range 0-14, higher is better

    Time frame: Month 6

  4. Hospital Anxiety and Depression Scale (HADS)

    Change in HADS survey questions, scores range from 0-42, lower score is better.

    Time frame: Day 0 to Month 3

  5. Hospital Anxiety and Depression Scale (HADS)

    Change in HADS survey questions, scores range from 0-42, lower score is better.

    Time frame: Day 0 to Month 6

  6. Multi-Dimensional Health Assessment Questionnaire (MDHAQ)

    Change in MDHAQ survey questions, scores range from 0 to 40, lower is better

    Time frame: Day 3 to Month 3

  7. Multi-Dimensional Health Assessment Questionnaire (MDHAQ)

    Change in MDHAQ survey questions, scores range from 0 to 40, lower is better

    Time frame: Day 3 to Month 6

  8. Patient Health Questionnaire -8

    Questions about mood, scores range from 0 to 32, lower is better

    Time frame: Day 0 to Month 3

  9. Patient Health Questionnaire -8

    Questions about mood, scores range from 0 to 32, lower is better

    Time frame: Day 0 to Month 6

  10. General Anxiety Disorder -7

    Questions about anxiety, scores range from 0 to 28, lower is better

    Time frame: Day 0 to month 3

  11. General Anxiety Disorder -7

    Questions about anxiety, scores range from 0 to 28, lower is better

    Time frame: Day 0 to month 6

  12. Perceived Deficits Questionnaire

    Questions about thinking functions, scores range from 0 to 80, lower is better

    Time frame: Day 0 to month 3

  13. Perceived Deficits Questionnaire

    Questions about thinking functions, scores range from 0 to 80, lower is better

    Time frame: Day 0 to month 6

  14. Single sleep questionnaire

    Question about sleep quality, score ranges from 0 to 10, higher is better

    Time frame: Day 0 to month 3

  15. Single sleep questionnaire

    Question about sleep quality, score ranges from 0 to 10, higher is better

    Time frame: Day 0 to month 6

  16. UCLA loneliness scale

    Question about loneliness, scores range from 20 to 80, lower is better

    Time frame: Day 0 to month 3

  17. UCLA loneliness scale

    Question about loneliness, scores range from 20 to 80, lower is better

    Time frame: Day 0 to month 6

07

Study locations

1 of 1 sites recruiting
  • Univeristy of Iowa
    Iowa City, Iowa 52246, United States
    Recruiting
    • Mary Ehlinger, BS · ContactCH-studies@uiowa.edu · 319-384-5002
    • Whitney Schley, BA · Contactwhitney-schley@uiowa.edu · (319) 356-8555
    • Terry Wahls, MD · Principal investigator
    • Linda Snetselaar, PhD, RD · Sub investigator
08

References and documents

Publications

  • Sandikci SC, Ozbalkan Z. Fatigue in rheumatic diseases. Eur J Rheumatol. 2015 Sep;2(3):109-113. doi: 10.5152/eurjrheum.2015.0029. Epub 2015 Sep 1. PubMed 27708942 ↗
  • Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996 Aug;23(8):1407-17. PubMed 8856621 ↗
  • Nikolaus S, Bode C, Taal E, van de Laar MA. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2013 Jul;65(7):1128-46. doi: 10.1002/acr.21949. PubMed 23335492 ↗
  • Omdal R, Mellgren SI, Koldingsnes W, Jacobsen EA, Husby G. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. J Rheumatol. 2002 Mar;29(3):482-6. PubMed 11908560 ↗
  • Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023 Feb;80:102266. doi: 10.1016/j.coi.2022.102266. Epub 2022 Nov 26. PubMed 36446151 ↗
  • Dean C, Parks S, Titcomb TJ, Arthofer A, Meirick P, Grogan N, Ehlinger MA, Bisht B, Fox SS, Daack-Hirsch S, Snetselaar LG, Wahls TL. Facilitators of and Barriers to Adherence to Dietary Interventions Perceived by Women With Multiple Sclerosis and Their Support Persons. Int J MS Care. 2022 Sep-Oct;24(5):235-241. doi: 10.7224/1537-2073.2021-051. Epub 2022 May 26. PubMed 36090239 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07180537
Lead sponsor
Terry L. Wahls
Responsible party
Terry L. Wahls (Clinical Professor, University of Iowa) — Sponsor-investigator
First posted
Sep 18, 2025
Start date
Dec 1, 2025
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Aug 10, 2026

Study contacts

Study Coordinator
Contact
ch-studies@uiowa.edu
319 384 5002
Mary Ehlinger, BS
Contact
AIM-Studies@uiowa.edu
319 384 5002
Terry L Wahls, MD, Other
principal investigator · University of Iowa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion